A Study to Assess Efficacy, Safety and Tolerability of the Anti-IL-13 Monoclonal Antibody QAX576 in the Treatment of Perinanal Fistulas in Patients Suffering From Crohn's Disease
Clinical trial NCT01316601 · COMPLETED
Trial details
- NCT number
- NCT01316601
- Sponsor
- Gerhard Rogler
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2012-11-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.